Research ArticleCancer
Eradication of spontaneous malignancy by local immunotherapy
- View ORCID ProfileIdit Sagiv-Barfi1,
- Debra K. Czerwinski1,
- Shoshana Levy1,
- Israt S. Alam2,
- View ORCID ProfileAaron T. Mayer2,
- View ORCID ProfileSanjiv S. Gambhir2 and
- View ORCID ProfileRonald Levy1,*
- 1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
- 2Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
- ↵*Corresponding author. Email: levy{at}stanford.edu
See allHide authors and affiliations
Science Translational Medicine 31 Jan 2018:
Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488
Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488
Idit Sagiv-Barfi
1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Debra K. Czerwinski
1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Shoshana Levy
1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Israt S. Alam
2Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Aaron T. Mayer
2Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Sanjiv S. Gambhir
2Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA 94305, USA.
Ronald Levy
1Division of Oncology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
